Related Experiment Video
Updated: May 22, 2026

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
Published on: January 16, 2026
sh-lncRNA-SNHG4 Regulates Cell Proliferation, Apoptosis, and EMT in Osteosarcoma Cells via Regulating miR-204-5p to
Zhennan Tian1, Huilei Qiu1, Yaoguo Lang2
1Pathology Department, Harbin Medical University Cancer Hospital, Harbin 150000, China.
Introduction:
To explore the function of the LncRNA SNHG4/miR-204-5p/LRP8 axis in the development of osteosarcoma (OS), especially in the process of epithelial-mesenchymal transition (EMT).
Methods:
The expression of SNHG4 was evaluated between various human OS cell lines, and 143B cell lines were screened out. Lentiviral vectors were used to interfere with the expression of SNHG4 and LRP8, while overexpressing the expression of miR-204-5p. The abilities of cell proliferation, migration, invasion, and apoptosis were evaluated by CCK-8, Transwell, and flow cytometry, respectively. The expression of related proteins (such as EMT markers, etc.) was detected by qRT-PCR and Western Blot. The dual-luciferase reporter gene assay verified the targeting relationship between miR-204-5p and LRP8. In vivo, the transplanted tumor model was established, and the role of this pathway was further verified, combined with immunohistochemistry and Western Blot.
Results:
SNHG4 is significantly highly expressed in OS cells, especially in 143B cells. In vivo, sh-lnc-SNHG4, ov-miR-204-5p, or sh-LRP8 can effectively inhibit the proliferation, migration, and invasion of OS cells and promote their apoptosis, while reversing the EMT process. SNHG4 may act as a competitive endogenous RNA to adsorb miR-204-5p, thereby relieving the inhibitory effect of miR-204-5p on its target gene LRP8 and further activating the Wnt/β-catenin pathway. In vivo experiments have confirmed that intervention in this pathway can significantly inhibit the growth of tumors in nude mice.
Discussion:
This study highlights the oncogenic role of lncRNA-SNHG4, which is highly expressed in OS and associated with tumor progression, while miR-204-5p has been reported to be a tumor suppressor. Inhibiting lncRNA- SNHG4 or overexpressing miR-204-5p suppressed OS cell proliferation, migration, invasion, and EMT, and promoted apoptosis by targeting LRP8. Consistently, sh-lnc-SNHG4 or ov-miR-204-5p reduced tumor growth and EMT in vivo.
Conclusion:
The lncRNA SNHG4/miR-204-5p/LRP8 axis plays a critical role in OS and may serve as a potential therapeutic target.
Insights
Long non-coding RNA SNHG4 promotes osteosarcoma (OS) progression by sponging miR-204-5p, leading to increased LRP8 expression and epithelial-mesenchymal transition (EMT). Inhibiting SNHG4 or restoring miR-204-5p suppresses OS growth and EMT.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma (OS) is a primary bone malignancy.
- The epithelial-mesenchymal transition (EMT) is crucial for OS progression and metastasis.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development.
Purpose of the Study:
- To investigate the functional role of the lncRNA SNHG4/miR-204-5p/LRP8 axis in osteosarcoma.
- To elucidate the involvement of this axis in the epithelial-mesenchymal transition (EMT) process in OS.
Main Methods:
- Assessed SNHG4 expression in OS cell lines.
- Utilized lentiviral vectors for gene expression manipulation (SNHG4, LRP8, miR-204-5p).
- Evaluated cell proliferation, migration, invasion, and apoptosis using CCK-8, Transwell, and flow cytometry.
- Confirmed targeting interactions using dual-luciferase reporter assays.
- Validated findings in vivo using a xenograft tumor model in nude mice.
Main Results:
- SNHG4 was highly expressed in OS cells, particularly in the 143B cell line.
- Interference with SNHG4 or LRP8, or overexpression of miR-204-5p, inhibited OS cell proliferation, migration, and invasion, while promoting apoptosis.
- This axis was shown to promote EMT and activate the Wnt/β-catenin pathway.
- In vivo studies confirmed that targeting this pathway significantly inhibited tumor growth and EMT.
Conclusions:
- lncRNA SNHG4 acts as an oncogene in OS, promoting tumor progression and EMT.
- miR-204-5p functions as a tumor suppressor within this axis.
- The SNHG4/miR-204-5p/LRP8 axis is a critical regulator of OS development and EMT.
- This axis represents a potential therapeutic target for osteosarcoma treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
